Overview of the Symposium
Understanding the molecular and biological diversity of rare diseases due to accumulated triglycerides and contributing to the global network of researchers, clinical practitioners, and patients
Osaka, Japan- The International Symposium on Triglyceride/Neutral Lipid and Rare Diseases will be held at the Kyoto International Conference Center on October 21 and 22, 2023. The symposium is organized by the International Symposium on Triglyceride/Neutral Lipid and Rare Diseases Conference Committee, which is led by Dr. Ken-ichi Hirano (Graduate School of Medicine, Osaka University) and the Japan Intractable Diseases (Nanbyo) Research Foundation.
A research team led by Dr. Hirano discovered a new intractable disease, "Triglyceride deposit cardiomyovasculopathy, (TGCV)," in 2008. TGCV is a new intractable disease of the body caused by the inability to utilize triglycerides in the body's cells, resulting in severe heart failure requiring transplantation of the body's primary cells. The research group has developed diagnostic and therapeutic methods to combat this rare disease.
The symposium will include 12 sessions over the course of two days with invited speakers from the United Kingdom, the Netherlands, Australia, South Korea, and the United States, as well as young travel grant recipients from Thailand and Indonesia.
The conference will also cover diseases and conditions in which triglycerides accumulate in the liver, kidney, and arteries. The aim is to deepen the understanding of the biology and disease diversity of TG-related rare diseases and to eliminate the isolation of patients, researchers, and medical professionals from disease information and treatment opportunities due to the rarity of these diseases.
Date: October 21 (Sat) - 22 (Sun), 2023 | online & on-site hybrid meeting
On-site venue: Kyoto International Conference Center, Japan
President: Ken-ichi Hirano, Department of Triglyceride Science, Graduate School of Medicine, Osaka University, Japan
Participation fee: U-41 free, 41 years or older JPY 5,000
Organizers: International Symposium on Triglyceride/Neutral Lipid and Rare Diseases Conference Committee, Japan Intractable Diseases Research Foundation
Contact: Professor Ken-ichi Hirano, Department of Triglyceride Science, Graduate School of Medicine, Osaka University, Japan ([email protected])
More information about the symposium can be found here: https://tgrare.org/en/
About Osaka University
Osaka University was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world, being named Japan's most innovative university in 2015 (Reuters 2015 Top 100) and one of the most innovative institutions in the world in 2017 (Innovative Universities and the Nature Index Innovation 2017). Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
